BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28539367)

  • 1. Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy.
    Meng G; Tang X; Yang Z; Benesch MGK; Marshall A; Murray D; Hemmings DG; Wuest F; McMullen TPW; Brindley DN
    FASEB J; 2017 Sep; 31(9):4064-4077. PubMed ID: 28539367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
    Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
    FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer.
    Brindley DN; Tang X; Meng G; Benesch MGK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression.
    Benesch MG; Tang X; Dewald J; Dong WF; Mackey JR; Hemmings DG; McMullen TP; Brindley DN
    FASEB J; 2015 Sep; 29(9):3990-4000. PubMed ID: 26071407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
    Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
    BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.
    Park SJ; Jun YJ; Lee KJ; Hwang SM; Kim TH; Lee SH; Lee SH
    Am J Rhinol Allergy; 2014; 28(3):199-207. PubMed ID: 24980231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Autotaxin⁻Lysophosphatidate Signaling-Related Proteins in Breast Cancer with Adipose Stroma.
    Cha YJ; Koo JS
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The autotaxin-LPA2 GPCR axis is modulated by γ-irradiation and facilitates DNA damage repair.
    Balogh A; Shimizu Y; Lee SC; Norman DD; Gangwar R; Bavaria M; Moon C; Shukla P; Rao R; Ray R; Naren AP; Banerjee S; Miller DD; Balazs L; Pelus L; Tigyi G
    Cell Signal; 2015 Sep; 27(9):1751-62. PubMed ID: 26027517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone Attenuates X-Ray-Induced Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle in Breast Tissue and Subsequent Breast Fibrosis.
    Meng G; Wuest M; Tang X; Dufour J; McMullen TPW; Wuest F; Murray D; Brindley DN
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32325715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.
    Benesch MG; Zhao YY; Curtis JM; McMullen TP; Brindley DN
    J Lipid Res; 2015 Jun; 56(6):1134-44. PubMed ID: 25896349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autotaxin stimulates LPA2 receptor in macrophages and exacerbates dextran sulfate sodium-induced acute colitis.
    Wang Z; Shi W; Tian D; Qin H; Vallance BA; Yang H; Yu HB; Yu Q
    J Mol Med (Berl); 2020 Dec; 98(12):1781-1794. PubMed ID: 33128578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling by lysophosphatidate and its health implications.
    Hemmings DG; Brindley DN
    Essays Biochem; 2020 Sep; 64(3):547-563. PubMed ID: 32451553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway.
    Zhang G; Cheng Y; Zhang Q; Li X; Zhou J; Wang J; Wei L
    Mol Med Rep; 2018 Mar; 17(3):4245-4252. PubMed ID: 29328374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy.
    Tang X; Benesch MGK; Brindley DN
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158716. PubMed ID: 32305571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated Fractions of X-Radiation to the Breast Fat Pads of Mice Augment Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle.
    Meng G; Wuest M; Tang X; Dufour J; Zhao Y; Curtis JM; McMullen TPW; Murray D; Wuest F; Brindley DN
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31752313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotaxin-LPA axis regulates hMSC migration by adherent junction disruption and cytoskeletal rearrangement via LPAR1/3-dependent PKC/GSK3β/β-catenin and PKC/Rho GTPase pathways.
    Ryu JM; Han HJ
    Stem Cells; 2015 Mar; 33(3):819-32. PubMed ID: 25376707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment.
    Venkatraman G; Benesch MG; Tang X; Dewald J; McMullen TP; Brindley DN
    FASEB J; 2015 Mar; 29(3):772-85. PubMed ID: 25398768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis.
    Samadi N; Gaetano C; Goping IS; Brindley DN
    Oncogene; 2009 Feb; 28(7):1028-39. PubMed ID: 19079345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autotaxin and LPA receptor signaling in cancer.
    Houben AJ; Moolenaar WH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proximal tubule LPA1 and LPA2 receptors use divergent signaling pathways to additively increase profibrotic cytokine secretion.
    Geng H; Lan R; Liu Y; Chen W; Wu M; Saikumar P; Weinberg JM; Venkatachalam MA
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F359-F374. PubMed ID: 33427061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.